Community pharmacy-based opiate substitution treatment and related health services: a study of 508 patients and 111 pharmacies
- 396 Downloads
Background and aims
Community pharmacies have a central role in the provision of opiate substitution therapy (OST) for drug misusers, offering accessible, additional health services within recovery-oriented systems of care. However, little is known about the patients receiving OST, availability and uptake of related services and associated pharmacy characteristics. We aimed to describe OST in terms of patients, pharmacies and services within the UK’s largest health authority, NHS Greater Glasgow and Clyde, Scotland.
Patients completed semi-structured questionnaires and pharmacists provided summary statistics relating to OST provision.
Responses from 508 patients receiving OST from 111 participating pharmacies revealed an established patient population, with 89 % (449/507) aged 30 years or above and 80 % (387/484) attending the same pharmacy for 1 year or more. Methadone was the main form of OST (96 % (487/508), with 97 % (491/504) receiving supervision. Within pharmacies, OST consumption was supervised in one of four main areas: consultation room, dispensing hatch, quiet/private area or over the counter. Location of supervision was considered suitably private by 96 % of patients. Positive staff attitudes, privacy and the provision of additional health services were key factors influencing choice of pharmacy. Additional health services were offered to 75 % of patients and included information provision (43 %), signposting to other health care providers (72 %) and a Scottish service offering free advice and medicines for minor ailments (74 %).
Patients and pharmacists have developed working relationships, enabling access to multiple services associated with health gain and harm reduction. Further development of enhanced services in community pharmacies is merited.
KeywordsMethadone OST Community pharmacy
The authors wish to thank Alex Adam, Janine Glen, Susie Heywood, Graeme Morrison and David Thomson for their assistance with data collation, literature review and manuscript development.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval and informed consent were not required for this study as it was an evaluation of a current service provided by NHS Greater Glasgow & Clyde (NHS GG&C). Research and Development (R&D) Management Approval was obtained prior to the initiation of the study. The study was undertaken in accordance with the ethical standards of NHS GG&C R&D and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
- Bloor R (2007) Supervised methadone in Staffordshire & Shropshire. A study of factors associated with key outcome variables. Research briefing 25. NHS National Treatment Agency for Substance Misuse, London. Available at: http://www.nta.nhs.uk/uploads/nta_rb25_supervised_methadone.pdf
- Chief Scientist Office (CSO) (2014) Community pharmacy services for drug misusers: measuring national service delivery and the development of professional attitudes over two decades. Reference CZH/4/998. Chief Scientist Office, Edinburgh. Available at: http://www.cso.scot.nhs.uk/wp-content/uploads/czh4998.pdf
- Department of Health (England) (DOH) and the Devolved Administrations (2007) Drug misuse and dependence: UK guidelines on clinical management. Department of Health (England), the Scottish Government, Welsh Assembly and Northern Ireland Executive, London. Available at: http://www.nta.nhs.uk/guidance.aspx
- Holland R, Matheson C, Anthony G, Roberts K, Priyadarshi S, Macrae A, Whitelaw E, Appavoo S, Bond C (2012) A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment. Drug Alcohol Rev 31:483–491CrossRefPubMedGoogle Scholar
- Information Services Division (ISD) (2010) Scottish Government Urban Rural Classification 2009–2010. ISD, Edinburgh. Available at: http://www.gov.scot/Publications/2010/08/2010UR
- Information Services Division (ISD) (2014) Estimating the prevalence of national and local problem drug use in Scotland 2012/13. ISD, Edinburgh. Available at: http://www.isdscotland.org/Health-Topics/Drugs-and-Alcohol-Misuse/Publications/2011-11-29/2011-11-29-DrugPrevalence-Report.pdf?
- Information Services Division (ISD) (2015) The National drug-related deaths database (Scotland) Report: Analysis of Deaths occurring in 2013. ISD, Edinburgh. Available at: http://www.isdscotland.org/Health-Topics/Drugs-and-Alcohol-Misuse/Publications/2015-04-28/2015-04-28-NDRDD-Report.pdf
- National Institute for Health and Care Excellence (NICE) (2007) Methadone and buprenorphine for the management of opioid dependence. NICE, London, Available at: http://www.nice.org.uk/guidance/ta114/resources/guidance-methadone-and-buprenorphine-for-the-management-of-opioid-dependence-pdf
- NHS Health Scotland (2009) Educational interventions to prevent hepatitis C: a review of the literature and expert opinion. NHS Health Scotland, Edinburgh, Available at: http://www.healthscotland.com/documents/3580.aspx
- Notley C, Holland R, Kouimtsidis C, Maskrey V, Robinson A, Swift L, Harvey I, Schifano F, Lowe A, Rosenbloom K (2014) Pharmacist and patient views of supervised consumption—findings from a randomised controlled trial and qualitative study of supervised consumption in patients managed with opiate maintenance treatment. Int J Pharm Pract 22(S1):19Google Scholar
- Palmateer NE, Taylor A, Goldberg DJ, Munro A, Aitken C, Shepherd SJ, McAllister G, Gunson R, Hutchinson SJ (2014) Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions. PLoS One 9(8):e104515CrossRefPubMedPubMedCentralGoogle Scholar
- Royal College of General Practitioners (RCGP) (2011) Guidance for the use of substitute prescribing in the treatment of opioid dependence in primary care. RCGP, London, Available at: http://www.rcgp.org.uk/clinical-and-research/clinical-resources/substance-misuse-resources-for-gps.aspx
- Scotland A (2012) Health inequalities in Scotland. Audit Scotland, Edinburgh, Available at: http://www.audit-scotland.gov.uk/docs/health/2012/nr_121213_health_inequalities.pdf
- Scottish Drug Strategy Delivery Commission (SDSDC) (2013) Independent expert review of opioid replacement therapies in Scotland. SDSDC, Edinburgh, Available at: http://www.gov.scot/Resource/0043/00431023.pdf
- Scottish Drugs Forum (SDF) (2007) on behalf of the Scottish Association of Alcohol and Drug Action Teams. Drugs and poverty: a literature review. SDF, Glasgow. Available at: http://www.sdf.org.uk/index.php/resources/publications/
- Scottish Drugs Forum (SDF) (2009) Older drug users in Scotland: professionals’ views. SDF, Glasgow, Available at: http://www.sdf.org.uk/resources/reports-and-research/#7
- Scottish Government (2008) The road to recovery: a new approach to tackling Scotland’s drug problem. The Scottish Government, Edinburgh, Available at: http://www.scotland.gov.uk/Publications/2008/05/22161610/12
- Scottish Government (2009) Establishing effective therapeutic partnerships—a generic framework to underpin the chronic medication service element of the community pharmacy contract. The Scottish Government Edinburgh, Edinburgh, Available at: http://www.gov.scot/Publications/2010/01/07144120/16
- Scottish Government (2011) The sexual health and blood borne virus framework 2011–15. The Scottish Government, Edinburgh, Available at: http://www.gov.scot/Resource/Doc/356286/0120395.pdf
- Scottish Government (2014) Service evaluation of Scotland’s national take-home naloxone programme. The Scottish Government, Edinburgh, Available at: http://www.gov.scot/Resource/0045/00451251.pdf
- Scottish Government Social Research (2009) Assessing the scale and impact of illicit drug markets in Scotland. The Scottish Government, Edinburgh, Available at: www.gov.scot/Publications/2009/10/06103906/0